Androgen Deprivation Therapy Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Class (Antiandrogens, Luteinizing Hormone Releasing Hormone (LHRH) Agonists, LHRH Antagonists, and Other Drug Classes); Mode of Administration (Injectable and Oral); Distribution Channel (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies), and Geography
Report Code: TIPRE00008561 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is carried out in men having prostate cancer. The pancreas is an androgen-dependent organ, and by providing ADT, it is possible to provide treatment for advanced and metastatic disease. Also, ADT is used along with external beam radiotherapy (EBRT) for intermediate to high-risk prostate cancer cases to improve responses to radiation. It is estimated that around 40% of patients diagnosed with prostate cancer would receive ADT within six months of diagnosis.
MARKET DYNAMICS
The androgen deprivation therapy market is anticipated to grow in the forecast, owing to the rise in the number of deaths caused due to prostate cancer, coupled with the rising demand for better medication. Also, the increase in R&D activities for the introduction of novel treatments for cancer is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Androgen Deprivation Therapy Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the androgen deprivation therapy market with detailed market segmentation by drug class, mode of administration, distribution channel, and geography. The androgen deprivation therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading androgen deprivation therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The androgen deprivation therapy market is segmented based on drug class, mode of administration, and distribution channel. Based on drug class, the market is segmented as antiandrogens, luteinizing hormone-releasing hormone (LHRH) agonists, LHRH antagonists, and other drug classes. Based on the mode of administration, the market is categorized as injectable and oral. Based on the distribution channel, the market is segmented as hospital pharmacies, online pharmacies, and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the androgen deprivation therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The androgen deprivation therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting androgen deprivation therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the androgen deprivation therapy market in these regions.
The report covers key developments in the androgen deprivation therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from androgen deprivation therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for androgen deprivation therapy market in the global market. Below mentioned is the list of few companies engaged in the androgen deprivation therapy market.
The report also includes the profiles of key androgen deprivation therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergan, Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca
- Bayer AG
- Johnson & Johnson Services, Inc.
- Orion Corporation
- Pfizer Inc.
- Sanofi
- Veru Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is carried out in men having prostate cancer. The pancreas is an androgen-dependent organ, and by providing ADT, it is possible to provide treatment for advanced and metastatic disease. Also, ADT is used along with external beam radiotherapy (EBRT) for intermediate to high-risk prostate cancer cases to improve responses to radiation. It is estimated that around 40% of patients diagnosed with prostate cancer would receive ADT within six months of diagnosis.
MARKET DYNAMICS
The androgen deprivation therapy market is anticipated to grow in the forecast, owing to the rise in the number of deaths caused due to prostate cancer, coupled with the rising demand for better medication. Also, the increase in R&D activities for the introduction of novel treatments for cancer is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Androgen Deprivation Therapy Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the androgen deprivation therapy market with detailed market segmentation by drug class, mode of administration, distribution channel, and geography. The androgen deprivation therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading androgen deprivation therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The androgen deprivation therapy market is segmented based on drug class, mode of administration, and distribution channel. Based on drug class, the market is segmented as antiandrogens, luteinizing hormone-releasing hormone (LHRH) agonists, LHRH antagonists, and other drug classes. Based on the mode of administration, the market is categorized as injectable and oral. Based on the distribution channel, the market is segmented as hospital pharmacies, online pharmacies, and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the androgen deprivation therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The androgen deprivation therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting androgen deprivation therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the androgen deprivation therapy market in these regions.
The report covers key developments in the androgen deprivation therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from androgen deprivation therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for androgen deprivation therapy market in the global market. Below mentioned is the list of few companies engaged in the androgen deprivation therapy market.
The report also includes the profiles of key androgen deprivation therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergan, Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca
- Bayer AG
- Johnson & Johnson Services, Inc.
- Orion Corporation
- Pfizer Inc.
- Sanofi
- Veru Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Androgen Deprivation Therapy Market - By Drug Class
1.3.2 Androgen Deprivation Therapy Market - By Mode of Administration
1.3.3 Androgen Deprivation Therapy Market - By Distribution Channel
1.3.4 Androgen Deprivation Therapy Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANDROGEN DEPRIVATION THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANDROGEN DEPRIVATION THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANDROGEN DEPRIVATION THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. ANDROGEN DEPRIVATION THERAPY - GLOBAL MARKET OVERVIEW
6.2. ANDROGEN DEPRIVATION THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIANDROGENS
7.3.1. Overview
7.3.2. Antiandrogens Market Forecast and Analysis
7.3.3. Bicalcutamide Market
7.3.3.1. Overview
7.3.3.2. Bicalcutamide Market Forecast and Analysis
7.3.4. Enzalutamide Market
7.3.4.1. Overview
7.3.4.2. Enzalutamide Market Forecast and Analysis
7.3.5. Flutamide Market
7.3.5.1. Overview
7.3.5.2. Flutamide Market Forecast and Analysis
7.3.6. Nilutamide Market
7.3.6.1. Overview
7.3.6.2. Nilutamide Market Forecast and Analysis
7.4. LUTEINIZING HORMONE RELEASING HORMONE (LHRH) AGONISTS
7.4.1. Overview
7.4.2. Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market Forecast and Analysis
7.4.3. Histrelin Market
7.4.3.1. Overview
7.4.3.2. Histrelin Market Forecast and Analysis
7.4.4. Leuprolide Market
7.4.4.1. Overview
7.4.4.2. Leuprolide Market Forecast and Analysis
7.4.5. Goserelin Market
7.4.5.1. Overview
7.4.5.2. Goserelin Market Forecast and Analysis
7.4.6. Triptorelin Market
7.4.6.1. Overview
7.4.6.2. Triptorelin Market Forecast and Analysis
7.5. LHRH ANTAGONISTS
7.5.1. Overview
7.5.2. LHRH Antagonists Market Forecast and Analysis
7.5.3. Abiraterone Market
7.5.3.1. Overview
7.5.3.2. Abiraterone Market Forecast and Analysis
7.5.4. Degarelix Market
7.5.4.1. Overview
7.5.4.2. Degarelix Market Forecast and Analysis
7.6. OTHER DRUG CLASSES
7.6.1. Overview
7.6.2. Other Drug Classes Market Forecast and Analysis
8. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ADMINISTRATION
8.1. OVERVIEW
8.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTABLE
8.3.1. Overview
8.3.2. Injectable Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
9. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. ANDROGEN DEPRIVATION THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Androgen Deprivation Therapy Market Overview
10.1.2 North America Androgen Deprivation Therapy Market Forecasts and Analysis
10.1.3 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.1.4 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.1.5 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States Androgen Deprivation Therapy Market
10.1.6.1.1 United States Androgen Deprivation Therapy Market by Drug Class
10.1.6.1.2 United States Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.1.3 United States Androgen Deprivation Therapy Market by Distribution Channel
10.1.6.2 Canada Androgen Deprivation Therapy Market
10.1.6.2.1 Canada Androgen Deprivation Therapy Market by Drug Class
10.1.6.2.2 Canada Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.2.3 Canada Androgen Deprivation Therapy Market by Distribution Channel
10.1.6.3 Mexico Androgen Deprivation Therapy Market
10.1.6.3.1 Mexico Androgen Deprivation Therapy Market by Drug Class
10.1.6.3.2 Mexico Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.3.3 Mexico Androgen Deprivation Therapy Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Androgen Deprivation Therapy Market Overview
10.2.2 Europe Androgen Deprivation Therapy Market Forecasts and Analysis
10.2.3 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.2.5 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Androgen Deprivation Therapy Market
10.2.6.1.1 Germany Androgen Deprivation Therapy Market by Drug Class
10.2.6.1.2 Germany Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.1.3 Germany Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.2 France Androgen Deprivation Therapy Market
10.2.6.2.1 France Androgen Deprivation Therapy Market by Drug Class
10.2.6.2.2 France Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.2.3 France Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.3 Italy Androgen Deprivation Therapy Market
10.2.6.3.1 Italy Androgen Deprivation Therapy Market by Drug Class
10.2.6.3.2 Italy Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.3.3 Italy Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.4 Spain Androgen Deprivation Therapy Market
10.2.6.4.1 Spain Androgen Deprivation Therapy Market by Drug Class
10.2.6.4.2 Spain Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.4.3 Spain Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.5 United Kingdom Androgen Deprivation Therapy Market
10.2.6.5.1 United Kingdom Androgen Deprivation Therapy Market by Drug Class
10.2.6.5.2 United Kingdom Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.5.3 United Kingdom Androgen Deprivation Therapy Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Androgen Deprivation Therapy Market Overview
10.3.2 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.3.5 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Androgen Deprivation Therapy Market
10.3.6.1.1 Australia Androgen Deprivation Therapy Market by Drug Class
10.3.6.1.2 Australia Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.1.3 Australia Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.2 China Androgen Deprivation Therapy Market
10.3.6.2.1 China Androgen Deprivation Therapy Market by Drug Class
10.3.6.2.2 China Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.2.3 China Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.3 India Androgen Deprivation Therapy Market
10.3.6.3.1 India Androgen Deprivation Therapy Market by Drug Class
10.3.6.3.2 India Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.3.3 India Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.4 Japan Androgen Deprivation Therapy Market
10.3.6.4.1 Japan Androgen Deprivation Therapy Market by Drug Class
10.3.6.4.2 Japan Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.4.3 Japan Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.5 South Korea Androgen Deprivation Therapy Market
10.3.6.5.1 South Korea Androgen Deprivation Therapy Market by Drug Class
10.3.6.5.2 South Korea Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.5.3 South Korea Androgen Deprivation Therapy Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Androgen Deprivation Therapy Market Overview
10.4.2 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.4.5 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Androgen Deprivation Therapy Market
10.4.6.1.1 South Africa Androgen Deprivation Therapy Market by Drug Class
10.4.6.1.2 South Africa Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.1.3 South Africa Androgen Deprivation Therapy Market by Distribution Channel
10.4.6.2 Saudi Arabia Androgen Deprivation Therapy Market
10.4.6.2.1 Saudi Arabia Androgen Deprivation Therapy Market by Drug Class
10.4.6.2.2 Saudi Arabia Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.2.3 Saudi Arabia Androgen Deprivation Therapy Market by Distribution Channel
10.4.6.3 U.A.E Androgen Deprivation Therapy Market
10.4.6.3.1 U.A.E Androgen Deprivation Therapy Market by Drug Class
10.4.6.3.2 U.A.E Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.3.3 U.A.E Androgen Deprivation Therapy Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Androgen Deprivation Therapy Market Overview
10.5.2 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis
10.5.3 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.5.5 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Androgen Deprivation Therapy Market
10.5.6.1.1 Brazil Androgen Deprivation Therapy Market by Drug Class
10.5.6.1.2 Brazil Androgen Deprivation Therapy Market by Mode of Administration
10.5.6.1.3 Brazil Androgen Deprivation Therapy Market by Distribution Channel
10.5.6.2 Argentina Androgen Deprivation Therapy Market
10.5.6.2.1 Argentina Androgen Deprivation Therapy Market by Drug Class
10.5.6.2.2 Argentina Androgen Deprivation Therapy Market by Mode of Administration
10.5.6.2.3 Argentina Androgen Deprivation Therapy Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANDROGEN DEPRIVATION THERAPY MARKET, KEY COMPANY PROFILES
12.1. ALLERGAN, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTELLAS PHARMA INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON & JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ORION CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VERU INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Androgen Deprivation Therapy Market - By Drug Class
1.3.2 Androgen Deprivation Therapy Market - By Mode of Administration
1.3.3 Androgen Deprivation Therapy Market - By Distribution Channel
1.3.4 Androgen Deprivation Therapy Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANDROGEN DEPRIVATION THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANDROGEN DEPRIVATION THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANDROGEN DEPRIVATION THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. ANDROGEN DEPRIVATION THERAPY - GLOBAL MARKET OVERVIEW
6.2. ANDROGEN DEPRIVATION THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIANDROGENS
7.3.1. Overview
7.3.2. Antiandrogens Market Forecast and Analysis
7.3.3. Bicalcutamide Market
7.3.3.1. Overview
7.3.3.2. Bicalcutamide Market Forecast and Analysis
7.3.4. Enzalutamide Market
7.3.4.1. Overview
7.3.4.2. Enzalutamide Market Forecast and Analysis
7.3.5. Flutamide Market
7.3.5.1. Overview
7.3.5.2. Flutamide Market Forecast and Analysis
7.3.6. Nilutamide Market
7.3.6.1. Overview
7.3.6.2. Nilutamide Market Forecast and Analysis
7.4. LUTEINIZING HORMONE RELEASING HORMONE (LHRH) AGONISTS
7.4.1. Overview
7.4.2. Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market Forecast and Analysis
7.4.3. Histrelin Market
7.4.3.1. Overview
7.4.3.2. Histrelin Market Forecast and Analysis
7.4.4. Leuprolide Market
7.4.4.1. Overview
7.4.4.2. Leuprolide Market Forecast and Analysis
7.4.5. Goserelin Market
7.4.5.1. Overview
7.4.5.2. Goserelin Market Forecast and Analysis
7.4.6. Triptorelin Market
7.4.6.1. Overview
7.4.6.2. Triptorelin Market Forecast and Analysis
7.5. LHRH ANTAGONISTS
7.5.1. Overview
7.5.2. LHRH Antagonists Market Forecast and Analysis
7.5.3. Abiraterone Market
7.5.3.1. Overview
7.5.3.2. Abiraterone Market Forecast and Analysis
7.5.4. Degarelix Market
7.5.4.1. Overview
7.5.4.2. Degarelix Market Forecast and Analysis
7.6. OTHER DRUG CLASSES
7.6.1. Overview
7.6.2. Other Drug Classes Market Forecast and Analysis
8. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ADMINISTRATION
8.1. OVERVIEW
8.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTABLE
8.3.1. Overview
8.3.2. Injectable Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
9. ANDROGEN DEPRIVATION THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. ANDROGEN DEPRIVATION THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Androgen Deprivation Therapy Market Overview
10.1.2 North America Androgen Deprivation Therapy Market Forecasts and Analysis
10.1.3 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.1.4 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.1.5 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 United States Androgen Deprivation Therapy Market
10.1.6.1.1 United States Androgen Deprivation Therapy Market by Drug Class
10.1.6.1.2 United States Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.1.3 United States Androgen Deprivation Therapy Market by Distribution Channel
10.1.6.2 Canada Androgen Deprivation Therapy Market
10.1.6.2.1 Canada Androgen Deprivation Therapy Market by Drug Class
10.1.6.2.2 Canada Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.2.3 Canada Androgen Deprivation Therapy Market by Distribution Channel
10.1.6.3 Mexico Androgen Deprivation Therapy Market
10.1.6.3.1 Mexico Androgen Deprivation Therapy Market by Drug Class
10.1.6.3.2 Mexico Androgen Deprivation Therapy Market by Mode of Administration
10.1.6.3.3 Mexico Androgen Deprivation Therapy Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Androgen Deprivation Therapy Market Overview
10.2.2 Europe Androgen Deprivation Therapy Market Forecasts and Analysis
10.2.3 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.2.5 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Androgen Deprivation Therapy Market
10.2.6.1.1 Germany Androgen Deprivation Therapy Market by Drug Class
10.2.6.1.2 Germany Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.1.3 Germany Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.2 France Androgen Deprivation Therapy Market
10.2.6.2.1 France Androgen Deprivation Therapy Market by Drug Class
10.2.6.2.2 France Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.2.3 France Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.3 Italy Androgen Deprivation Therapy Market
10.2.6.3.1 Italy Androgen Deprivation Therapy Market by Drug Class
10.2.6.3.2 Italy Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.3.3 Italy Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.4 Spain Androgen Deprivation Therapy Market
10.2.6.4.1 Spain Androgen Deprivation Therapy Market by Drug Class
10.2.6.4.2 Spain Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.4.3 Spain Androgen Deprivation Therapy Market by Distribution Channel
10.2.6.5 United Kingdom Androgen Deprivation Therapy Market
10.2.6.5.1 United Kingdom Androgen Deprivation Therapy Market by Drug Class
10.2.6.5.2 United Kingdom Androgen Deprivation Therapy Market by Mode of Administration
10.2.6.5.3 United Kingdom Androgen Deprivation Therapy Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Androgen Deprivation Therapy Market Overview
10.3.2 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.3.5 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Androgen Deprivation Therapy Market
10.3.6.1.1 Australia Androgen Deprivation Therapy Market by Drug Class
10.3.6.1.2 Australia Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.1.3 Australia Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.2 China Androgen Deprivation Therapy Market
10.3.6.2.1 China Androgen Deprivation Therapy Market by Drug Class
10.3.6.2.2 China Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.2.3 China Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.3 India Androgen Deprivation Therapy Market
10.3.6.3.1 India Androgen Deprivation Therapy Market by Drug Class
10.3.6.3.2 India Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.3.3 India Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.4 Japan Androgen Deprivation Therapy Market
10.3.6.4.1 Japan Androgen Deprivation Therapy Market by Drug Class
10.3.6.4.2 Japan Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.4.3 Japan Androgen Deprivation Therapy Market by Distribution Channel
10.3.6.5 South Korea Androgen Deprivation Therapy Market
10.3.6.5.1 South Korea Androgen Deprivation Therapy Market by Drug Class
10.3.6.5.2 South Korea Androgen Deprivation Therapy Market by Mode of Administration
10.3.6.5.3 South Korea Androgen Deprivation Therapy Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Androgen Deprivation Therapy Market Overview
10.4.2 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.4.5 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Androgen Deprivation Therapy Market
10.4.6.1.1 South Africa Androgen Deprivation Therapy Market by Drug Class
10.4.6.1.2 South Africa Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.1.3 South Africa Androgen Deprivation Therapy Market by Distribution Channel
10.4.6.2 Saudi Arabia Androgen Deprivation Therapy Market
10.4.6.2.1 Saudi Arabia Androgen Deprivation Therapy Market by Drug Class
10.4.6.2.2 Saudi Arabia Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.2.3 Saudi Arabia Androgen Deprivation Therapy Market by Distribution Channel
10.4.6.3 U.A.E Androgen Deprivation Therapy Market
10.4.6.3.1 U.A.E Androgen Deprivation Therapy Market by Drug Class
10.4.6.3.2 U.A.E Androgen Deprivation Therapy Market by Mode of Administration
10.4.6.3.3 U.A.E Androgen Deprivation Therapy Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Androgen Deprivation Therapy Market Overview
10.5.2 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis
10.5.3 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Mode of Administration
10.5.5 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Androgen Deprivation Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Androgen Deprivation Therapy Market
10.5.6.1.1 Brazil Androgen Deprivation Therapy Market by Drug Class
10.5.6.1.2 Brazil Androgen Deprivation Therapy Market by Mode of Administration
10.5.6.1.3 Brazil Androgen Deprivation Therapy Market by Distribution Channel
10.5.6.2 Argentina Androgen Deprivation Therapy Market
10.5.6.2.1 Argentina Androgen Deprivation Therapy Market by Drug Class
10.5.6.2.2 Argentina Androgen Deprivation Therapy Market by Mode of Administration
10.5.6.2.3 Argentina Androgen Deprivation Therapy Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANDROGEN DEPRIVATION THERAPY MARKET, KEY COMPANY PROFILES
12.1. ALLERGAN, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTELLAS PHARMA INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON & JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ORION CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VERU INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Allergan, Inc.
2. Amgen Inc.
3. Astellas Pharma Inc.
4. AstraZeneca
5. Bayer AG
6. Johnson & Johnson Services, Inc.
7. Orion Corporation
8. Pfizer Inc.
9. Sanofi
10. Veru Inc.
1. Allergan, Inc.
2. Amgen Inc.
3. Astellas Pharma Inc.
4. AstraZeneca
5. Bayer AG
6. Johnson & Johnson Services, Inc.
7. Orion Corporation
8. Pfizer Inc.
9. Sanofi
10. Veru Inc.